Join a powerful, unprecedented alliance for better eye health for all.
Join IAPB-
Choose an alternate language here
Through innovation in the scientific discovery of new potential drug targets, personalised healthcare, molecular engineering, biomarkers and continuous drug delivery, Roche strives to design the right therapies for the right patients.
With a robust pipeline, rationalised in science and informed by insights from people with eye diseases, Roche has the broadest late stage retina pipeline including treatments for neovascular age-related macular degeneration, diabetic macular edema, diabetic retinopathy and retinal vein occlusion. Our early stage pipeline also includes gene therapies and treatments for geographic atrophy and other vision-threatening diseases, including rare and inherited conditions.
As a sponsor of International Agency for the Prevention of Blindness, Roche has provided a sponsorship which has been utilised to support our activities. Roche has no influence over these activities or the development of any associated content, events, or other materials.
Grenzacherstrasse 124 4070 Basel Switzerland
Website www.roche.com
